Assuntos
Animais de Laboratório , Ciência dos Animais de Laboratório/economia , Apoio à Pesquisa como Assunto , Pesquisa/economia , Bem-Estar do Animal , Animais , Custos e Análise de Custo , Financiamento Governamental , Ciência dos Animais de Laboratório/educação , National Institutes of Health (U.S.)/economia , Estados Unidos , Medicina Veterinária/economiaRESUMO
Genetically susceptible BALB/c mice were immunized i.m. with DNA for one or two Mycoplasma pulmonis Ags (A7-1, A8-1) beginning either 1 wk before (vaccination) or 1 wk after (treatment) intranasal infection with 5 x 10(4) CFU virulent M. pulmonis organisms. Immunization of mice by this method induced both humoral and cellular immunity to M. pulmonis, largely prevented infection (vaccination), and cleared an ongoing pneumonia over time (treatment). Only one Ag gene was required. Thus, DNA immunization is a potential treatment for infections and may be useful in instances when drug therapy may not be available or effective.
Assuntos
Infecções por Mycoplasma/genética , Infecções por Mycoplasma/prevenção & controle , Mycoplasma/imunologia , Pneumonia Bacteriana/genética , Pneumonia Bacteriana/prevenção & controle , Vacinas de DNA/imunologia , Vacinas de DNA/uso terapêutico , Animais , Anticorpos Antibacterianos/biossíntese , Suscetibilidade a Doenças , Feminino , Genes Bacterianos/imunologia , Injeções Intramusculares , Camundongos , Camundongos Endogâmicos BALB C , Mycoplasma/genética , Mycoplasma/patogenicidade , Infecções por Mycoplasma/terapia , Pneumonia Bacteriana/terapia , VirulênciaRESUMO
Strains of mice differ greatly in resistance to infection in their lungs with virulent Mycoplasma pulmonis (MP) organisms even during the first 5 days, prior to detection of humoral or T cell mediated acquired immune responses. C57BL/6 mice are resistant, and BALB/c and C3H mice are susceptible, and one major gene, MP, not linked to the H2 major histocompatibility complex, regulates resistance. C57BL/6 x C3H (B x H) and BALB/c x C57BL/6 (C x B) recombinant inbred strain mice were infected intratracheally with the T2 strain of MP. Five days later, the recovery of organisms from tracheolung lavages and lung tissue was determined. The strain distribution pattern of resistance indicated that the MP gene maps to chromosome 4. B6.C-H18 (B6 mice congenic for the BALB/c H18 gene of chromosome 4) were much more susceptible than B6 mice, but were less susceptible than BALB/c mice, supporting the data obtained with the recombinant inbred strain mice, but suggesting that other genes may also influence resistance to infection with MP.
Assuntos
Mapeamento Cromossômico , Camundongos Endogâmicos BALB C/imunologia , Camundongos Endogâmicos C3H/imunologia , Camundongos Endogâmicos C57BL/imunologia , Infecções por Mycoplasma/imunologia , Pneumonia Bacteriana/imunologia , Animais , Líquido da Lavagem Broncoalveolar/microbiologia , Cruzamentos Genéticos , Feminino , Imunidade Inata , Pulmão/microbiologia , Masculino , Camundongos , Infecções por Mycoplasma/genética , Pneumonia Bacteriana/genética , Organismos Livres de Patógenos EspecíficosRESUMO
The induction of an immune response against a foreign protein usually requires purification of that protein, which is injected into animals. The isolation of pure protein is time consuming and costly. Recently, a technique called biolistic transformation (biological ballistic system) microparticle injection, gene gun, or particle bombardment was developed. The basic idea is that DNA or biological material coated onto heavy tungsten or gold particles is shot into target cells or animals. We have vaccinated mice by introducing the gene (Mycoplasma pulmonis DNA or a specific fragment) encoding a protein recognized by a protective monoclonal antibody directly into the skin or muscle of mice by two methods: (i) using a hand-held form of the biolistic system that can propel DNA-coated gold microprojectiles (2 micrograms of DNA) directly into the skin; (ii) using a conventional intramuscular injection of the DNA (100 micrograms) into quadricep muscles of transfected mice. HeLa cells were transfected in vitro by the gene gun or by the liposomal delivery system. Indirect immuno-fluorescent antibody (IFA) assay of culture cells indicated that both methods could be successful. Production of antibody and cell-mediated immunity against M.pulmonis were monitored by assaying serum IFA and enzyme-linked immunosorbent assay (ELISA), and delayed type hypersensitivity. In addition, macrophage migration inhibition and lymphocyte transformation to antigen in spleen cells were also tested. Both delivery systems induced humoral and cellular immunity, and vaccinated the mice against infection. Genetic immunization by using the gene gun saves time, money, and labor; moreover, this general method is also applicable to gene therapy.
Assuntos
Vacinas Bacterianas , DNA Bacteriano/imunologia , Genes Bacterianos , Infecções por Mycoplasma/imunologia , Mycoplasma/genética , Animais , Formação de Anticorpos , Antígenos de Bactérias/análise , Antígenos de Bactérias/biossíntese , Sequência de Bases , Primers do DNA , DNA Bacteriano/genética , Feminino , Biblioteca Genômica , Células HeLa , Humanos , Camundongos , Camundongos Endogâmicos BALB C , Dados de Sequência Molecular , Infecções por Mycoplasma/prevenção & controle , Reação em Cadeia da Polimerase , Proteínas Recombinantes/análise , Proteínas Recombinantes/biossínteseRESUMO
Results of competitive binding studies with radiolabeled and unlabeled Mycoplasma pulmonis and rat tracheal explant cultures indicated no effect of trypsin treatment on the ability of M. pulmonis to bind to explants. A trypsin-resistant 46-kDa membrane protein, which binds isolated rat tracheal epithelial cells in culture, was purified and used to produce specific antibodies that block adhesion of mycoplasmas to tracheal explants. These results suggest that M. pulmonis adheres to rat tracheal epithelium via a trypsin-resistant 46-kDa protein.
Assuntos
Aderência Bacteriana , Proteínas de Bactérias/metabolismo , Mycoplasma/metabolismo , Traqueia/microbiologia , Animais , Anticorpos/farmacologia , Proteínas de Bactérias/imunologia , Ligação Competitiva , Epitélio/microbiologia , Masculino , Peso Molecular , Mycoplasma/química , Ratos , Ratos Endogâmicos Lew , Tripsina/farmacologiaRESUMO
A construct of the Mycoplasma pulmonis (MP) genomic library, using randomly sheared DNA, was cloned in lambda gt11 and transfected into C600 Escherichia coli organisms. Clones of E. coli expressing a fusion protein reactive with anti-MP and monospecific serum were transferred orally or intravenously into Balb/c mice. Expression of the fusion protein was induced by adding isopropyl-beta-D-thiogalactopyranoside to the drinking water. This vaccination protocol led to local and systemic antibody formation, to generation of immune lymphocytes and to protection against large numbers of virulent MP organisms. This approach might be generally successful in preventing infectious disease.
Assuntos
Vacinas Bacterianas/imunologia , Escherichia coli/genética , Infecções por Mycoplasma/prevenção & controle , Mycoplasma/imunologia , Vacinas Sintéticas/imunologia , Administração Oral , Sequência de Aminoácidos , Animais , Sequência de Bases , Western Blotting , Eletroforese em Gel de Poliacrilamida , Feminino , Biblioteca Genômica , Injeções Intravenosas , Lisogenia , Camundongos , Camundongos Endogâmicos BALB C , Dados de Sequência Molecular , Transfecção/métodosRESUMO
The differences in susceptibility of various inbred strains of mice to a highly pathogenic strain of Mycoplasma pulmonis CT (T2) has been known for some time. We assessed the genetic control of resistance to T2 infection. Tracheolung lavage samples and lungs of mice were assessed for T2 organisms after intratracheal injection of T2. We found that H-2b (C57BL/6 (B6) and H-2k B10.BR mice were resistant, whereas H-2b A.By, H-2k C3H/Bi, H-2k C3H/HeJ (C3H), and H-2b BALB.B mice were susceptible. We also typed individual B6C3F2 mice for H-2 and for resistance to T2 and observed that resistance to T2 infections is controlled by a single dominant gene not linked to H-2. Histologic examination revealed severe lung lesions typical of M. pulmonis infections in susceptible C3H mice, in contrast to minimal lung lesions in resistant B6 mice. No significant titers of local or systemic antimycoplasma antibodies were detected in either resistant or susceptible mice at 5 days postinfection. Macrophages taken from uninfected B6 or C3H mice failed to inhibit growth of T2 in vitro. However, macrophages from B6 mice did inhibit growth of T2 much better than C3H macrophages when harvested on day 5 of infection. Thus, there is an association between activation of macrophage bactericidal function and genetic resistance to growth of T2 organisms.
Assuntos
Infecções por Mycoplasma/imunologia , Animais , Anticorpos Antibacterianos/análise , Feminino , Genes Dominantes , Antígenos H-2/genética , Imunidade Inata/genética , Macrófagos/imunologia , Macrófagos/microbiologia , Masculino , Camundongos , Camundongos Endogâmicos C3H , Camundongos Endogâmicos C57BL , Mycoplasma/crescimento & desenvolvimento , Mycoplasma/imunologia , Infecções por Mycoplasma/genética , Infecções por Mycoplasma/patologiaRESUMO
The protective efficacy of a vaccine purified from the Pasteurella multocida 3:A outer membrane (OM) was evaluated in rabbits by homologous challenge. Twenty-seven rabbits were divided into four groups: 1, vaccinated with OM and challenged; 2, nonvaccinated and challenged; 3, vaccinated with OM only; and 4, nonvaccinated and not challenged. Rabbits were immunized intranasally with 1 mg of OM protein on days 0, 7, 14, and 35, challenged intranasally on day 49, and killed on day 63. Mortality rates were 0, 67, 0, and 0% for groups 1 through 4, respectively. The prevalence of pneumonia was reduced from 73 (group 2) to 20% (group 1). The severity of pneumonia was reduced from 0.62 (group 2) to 0.07 (group 1), as measured by the group lesion index. The number of P. multocida in nasal cavities was reduced from 3.89 x 10(5) (group 2) to 6.19 x 10(2) (group 1). The geometric mean number of P. multocida in lungs was 8,360,000-fold less in group 1 than in group 2. Similarly, the prevalence of P. multocida colonization in nonrespiratory organs was reduced from 47 (group 2) to 4% (group 1). Furthermore, group 1 and 3 rabbits developed significantly elevated immunoglobulin A antibodies in nasal secretions and lung lavages and significantly elevated immunoglobulin G antibodies in lung lavages and sera. In addition, rabbit immune sera contained antibodies against P. multocida OM proteins and lipopolysaccharides and inhibited P. multocida proliferation in mouse lungs. These results indicate that a vaccine prepared from the OM of P. multocida provides a significant protection in rabbits against homologous challenge.
Assuntos
Proteínas da Membrana Bacteriana Externa/imunologia , Vacinas Bacterianas/imunologia , Pasteurella multocida/imunologia , Animais , Anticorpos Antibacterianos/análise , Ensaio de Imunoadsorção Enzimática , Feminino , Soros Imunes/imunologia , Imunização , Immunoblotting , Imunoglobulina A/análise , Cavidade Nasal/microbiologia , Infecções por Pasteurella/prevenção & controle , Pasteurella multocida/isolamento & purificação , Pneumonia/prevenção & controle , Coelhos , Rinite/prevenção & controleRESUMO
Severe combined immunodeficient (SCID) mice are becoming increasingly popular as research animals; as a consequence, more efforts to produce congenic strains carrying the scid gene are underway. In an attempt to conserve time and resources in this endeavor, we used peripheral blood differential white blood cell counts as a preliminary screen to eliminate the homozygous (+/+) wild type and heterozygous (scid/+) animals from intercross generations. The results of our investigation confirm that blood smears can be used as a screen at four weeks of age to identify animals having an inversion of the granulocyte:mononuclear cell ratio. Mice not having an inversion of this ratio, i.e., mononuclear cells exceeding 50%, can be eliminated from the colony. This screen permits elimination of a large portion of the intercross generation one month earlier than other methods that rely on detection of serum immunoglobulin. The screen is highly sensitive and specific. We do not propose that this screen be used as a definitive test but as a tool to eliminate the majority of animals that are not homozygous at the scid locus.
Assuntos
Contagem de Leucócitos , Camundongos SCID/sangue , Imunodeficiência Combinada Severa/diagnóstico , Animais , Cruzamentos Genéticos , Feminino , Triagem de Portadores Genéticos/métodos , Homozigoto , Immunoblotting , Masculino , Camundongos , Camundongos SCID/genética , Imunodeficiência Combinada Severa/sangue , Imunodeficiência Combinada Severa/genéticaRESUMO
The role of rabbit antibodies against Pasteurella multocida outer membrane proteins and lipopolysaccharides (LPS) in resistance remains unknown. Pooled immune sera against P. multocida outer membranes were prepared from specific-pathogen-free rabbits immunized with sucrose gradient-purified P. multocida outer membranes. Western immunoblotting showed that purified outer membrane protein antibodies reacted strongly against the outer membrane proteins but not the purified LPS. Affinity-purified LPS antibodies exhibited strong reactivity against purified LPS and very little reactivity against outer membrane vesicles. Mice were inoculated intranasally with immune serum or normal rabbit serum, challenged intranasally with 10(6) CFU of P. multocida, and euthanatized 48 h later to determine the number of P. multocida organisms in the lungs. Mice inoculated with pooled immune serum had a 3,300-fold reduction (P less than 0.001) in the numbers of P. multocida in the lungs as compared with the controls. Similarly, mice inoculated with purified outer membrane protein antibodies had a 201-fold reduction (P less than 0.001) in the numbers of P. multocida. Conversely, mice inoculated with affinity-purified LPS antibodies had a 1.1-fold reduction (P greater than 0.50) in the numbers of P. multocida. These results show that antibodies against the outer membrane proteins but not the LPS are the components of rabbit immune sera which inhibit P. multocida proliferation in mouse lungs.
Assuntos
Anticorpos Antibacterianos/imunologia , Proteínas da Membrana Bacteriana Externa/imunologia , Lipopolissacarídeos/imunologia , Pulmão/microbiologia , Pasteurella/imunologia , Animais , Anticorpos Antibacterianos/análise , Western Blotting , Feminino , Soros Imunes/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Pasteurella/crescimento & desenvolvimento , CoelhosRESUMO
Monoclonal antibodies (mAbs) were produced against Mycoplasma pulmonis (MP); some were highly protective in the treatment of experimental infections of BALB/c mice. The mAbs inhibited MP growth in vitro and prevented the attachment of MP to fibroblasts or to red blood cells. Three separate mAbs recognized 54-76% of 54 clinical isolates of MP, and the three together detected all 54 isolates. We used the mAbs to purify the antigens by affinity column chromatography. The purified antigen used to vaccinate mice and to immunize rabbits produced antibodies capable of significant growth inhibition in sera and tracheolung lavage fluids. The vaccinated mice were challenged with various doses of a highly virulent T2 strain of MP. Assays for viable MP organisms and for histopathological changes in the lungs of infected mice indicated that mice were protected if the challenge dose was 10(3)-10(5), but not 10(7), c.f.u. The sera of immunized rabbits were used to passively transfer immunity to mice. The sera provided complete protection against 1 x 10(6) c.f.u. T2 MP. We conclude that MP antigens purified by this protocol can provide a safe vaccine against this disease, at least in mice.
Assuntos
Anticorpos Monoclonais/imunologia , Antígenos de Bactérias/isolamento & purificação , Vacinas Bacterianas/imunologia , Infecções por Mycoplasma/prevenção & controle , Mycoplasma/imunologia , Animais , Anticorpos Antibacterianos/biossíntese , Antígenos de Bactérias/imunologia , Cromatografia de Afinidade , Imunização Passiva , Camundongos , Camundongos Endogâmicos BALB C , Infecções por Mycoplasma/imunologia , Coelhos , Organismos Livres de Patógenos EspecíficosRESUMO
Monoclonal antibodies (MAbs) directed against the 37.5-kDa outer membrane protein were produced by fusing myeloma cells with spleen cells obtained from mice immunized with a pathogenic strain of Pasteurella multocida isolated from a rabbit. Desirable MAbs were selected by enzyme-linked immunosorbent assay, whole-cell radioimmunoprecipitation (WC-RIP), and Western blot (immunoblot) analysis. WC-RIP and Western blot analyses, using MAb 1608 adsorbed with intact P. multocida cells and the eluted MAb, demonstrated that the antigen recognized by this MAb is exposed on the cell surface, is antibody accessible, and has an estimated molecular mass of 37.5 kDa. Treatment of outer membrane vesicles of P. multocida with proteinase K totally abrogated the MAb 1608 activity, indicating that this MAb binds to a protein antigenic determinant. Furthermore, MAb 1608 was nonreactive to purified lipopolysaccharide in Western blot analysis. Passive transfer studies showed that nine rabbits inoculated intranasally with MAb 1608 and homologously challenged intranasally had significantly reduced mortality, severity of pneumonia, prevalence of P. multocida colonization in nonrespiratory organs, and numbers of P. multocida in nasal cavities compared with the controls. Furthermore, the number of P. multocida in lungs was reduced 84,750-fold. Similarly, passive transfer experiments indicated that MAb 1608 protected mice against homologous and heterologous challenges with P. multocida strains bearing the antigenic determinant recognized by MAb 1608. However, no protection was afforded by MAb 1608 when mice were challenged with a P. multocida strain lacking the antigenic determinant recognized by MAb 1608. This study establishes that the 37.5-kDa outer membrane protein is the target for a protective MAb.
Assuntos
Anticorpos Monoclonais/imunologia , Proteínas da Membrana Bacteriana Externa/imunologia , Infecções por Pasteurella/prevenção & controle , Pasteurella/imunologia , Animais , Especificidade de Anticorpos , Feminino , Imunização , Camundongos , Camundongos Endogâmicos BALB C , Pasteurella/patogenicidade , Coelhos , VirulênciaRESUMO
Temperature-sensitive mutant vaccines protect rats against Mycoplasma pulmonis infection. The role of the humoral or cellular immune response in resistance to mycoplasma infection was investigated by adoptive-transfer experiments. Spleen cells from Lewis rats vaccinated but not challenged with wild-type organisms (vaccinated) and spleen cells from rats vaccinated (or not) and challenged were effective in preventing syngeneic recipients from developing respiratory disease. There was also a significant reduction in the incidence and number of challenging organisms in the respiratory system. In contrast, sera from the same donors had no detectable effect on the number of mycoplasmas recovered or on lesion development in the respiratory tract. We conclude that cellular immunity rather than humoral immunity generated in vaccinated rats confers protection against subsequent infection.
Assuntos
Imunização Passiva , Imunoterapia Adotiva , Mycoplasma/imunologia , Baço/imunologia , Animais , Feminino , Pulmão/patologia , Masculino , Mutação , Mycoplasma/isolamento & purificação , Infecções por Mycoplasma/imunologia , Infecções por Mycoplasma/patologia , Ratos , Ratos Endogâmicos Lew , Linfócitos T/imunologia , Temperatura , VacinaçãoRESUMO
Although most people support the appropriate use of animals for research and safety testing, the public expects that animals will be treated in a humane manner. The advancement of science and the ethical considerations of animal use are not antithetical. Toxicologists should be cognizant that animal pain and distress may result from their studies and should recognize their duty in minimizing or preventing this potential outcome. While the ultimate responsibility for preventing animal pain and distress is with the individual toxicologist, the responsibility for the well-being of laboratory animals is shared with the Institutional Animal Care and Use Committee (IACUC) and the veterinary staff. The role of the veterinarian in working with toxicologists to refine animal studies is multifaceted and includes such activities as assisting in the planning stages of studies and in presubmission review of protocols, providing training in anticipation and recognition of pain and distress, providing information concerning pharmacologic and nonpharmacologic methods for alleviating or minimizing pain and distress, providing a high quality animal care and health program to support studies, and assisting toxicology staff in monitoring all phases of the study and in addressing problems in a timely manner. Veterinarians, toxicologists and IACUCs are faced with a significant, but not insurmountable, challenge in the prevention and alleviation of pain in research animals. We are beginning to categorize and agree upon subjective signs of pain and distress in various laboratory species. More research is required to develop more objective methods for recognizing pain and for providing better methods for prevention and alleviation.
Assuntos
Alternativas aos Testes com Animais/tendências , Animais de Laboratório/fisiologia , Toxicologia/tendências , Medicina Veterinária/tendências , Animais , Dor/psicologia , Medição da Dor , Projetos de PesquisaRESUMO
Temperature-sensitive mutants (TSMs) of Mycoplasma pulmonis were produced by treating the wild-type strain with N-methyl-N'-nitro-N-nitrosoguanidine. Three TSMs were selected at 38 degrees C, as a restrictive temperature, and at 34 degrees C, as a permissive temperature. Two TSMs, UTCMI and UTCMII, were proven to be nonpathogenic but immunogenic. In addition, they did not induce pneumonia, tracheitis, or tympanitis but did induce mild rhinitis. They were stable after 10 passages in vitro and in vivo. They elicited excellent antibody production and cell-mediated immunity in vaccinated rats. They also were not mitogenic to rat lymphocytes. Rats immunized intranasally with these TSMs were significantly protected against challenge with wild-type organisms. These mutants were morphologically and serologically indistinguishable from the wild-type organisms. The growth characteristics and antibiotic sensitivities were similar to those of wild-type organisms, except that they grew only at 34 degrees C. In contrast to wild-type organisms, they did not bind to or lyse sheep erythrocytes. Thus, these TSMs may qualify as a vaccine to prevent M. pulmonis infection in rats.
Assuntos
Vacinas Bacterianas/imunologia , Infecções por Mycoplasma/prevenção & controle , Animais , Anticorpos Antibacterianos/biossíntese , Feminino , Pulmão/microbiologia , Masculino , Mutação , Mycoplasma/genética , Mycoplasma/imunologia , Mycoplasma/patogenicidade , Infecções por Mycoplasma/veterinária , Cavidade Nasal/microbiologia , Ratos , Ratos Endogâmicos Lew , Doenças dos Roedores/prevenção & controle , Temperatura , Vacinas Atenuadas/imunologiaRESUMO
Infection of C57BL/6J mice with Mycoplasma pulmonis (MP) enhanced NK cell function 3-7 days later, as detected by in vitro and in vivo assays. Moreover, spleen and lung cells of acutely infected C57BL/6J mice inhibited MP growth in vitro. The effectors were eliminated by treatment with anti-NK antibody in vivo and anti-asialo GM1 serum or anti-3A4 antibody plus complement in vitro. Clearance of viable and radiolabeled MP from the lungs was also enhanced in acutely infected mice. Acutely infected mice with severe combined immunodeficiency (SCID) eliminated viable MP faster than did uninfected mice. Antibodies to interferon-gamma (IFN-gamma) impaired clearance of MP from the lungs of SCID mice and decreased their survival times. Activated NK cells can function in resistance to early stages of infection with MP. NK cells directly inhibit MP with secrete IFN-gamma, which may activate macrophages or inhibit the growth of MP or both.
Assuntos
Células Matadoras Naturais/imunologia , Infecções por Mycoplasma/imunologia , Mycoplasma/imunologia , Animais , Imunidade Celular , Pulmão/citologia , Pulmão/imunologia , Neoplasias Pulmonares/secundário , Masculino , Melanoma/secundário , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Mutantes , Organismos Livres de Patógenos Específicos , Baço/citologia , Baço/imunologia , Células Tumorais CultivadasRESUMO
Humoral and cell-mediated immune responses to sheep red blood cells (SRBC) were studied in mice infected experimentally with Mycoplasma pulmonis. The hemagglutinating (HA) antibody against SRBC was evaluated at 0, 3, 5, 7, 14, 21 and 28 days postinfection (PI). Antibody tiers during all days PI were depressed significantly (p less than 0.05) in infected mice as compared to noninfected controls. The HA antibody, which is of the IgM class, peaks at day 5 PI. There is no shift in the kinetics of the humoral response in M. pulmonis infected mice. Cellular immune responses were evaluated by a delayed-type hypersensitivity (DTH) reaction and the lymphocyte transformation technique. Mice were sensitized at 0,3,5,7,14, 21 and 28 days PI with SRBC and challenged by footpad injection of SRBC 7 days later. The DTH reaction measured at 24 hours after challenge was depressed significantly (p less than 0.05) in all infected animals. After a transient enhancement on day 3 PI, the DTH responses remained depressed through day 28 PI. The lymphocyte transformation test showed a significantly (p less than 0.05) depressed response except on days 5 and 7 PI. These results indicate that M. pulmonis infection in mice suppresses the humoral antibody and cell-mediated immune responses.
Assuntos
Camundongos Endogâmicos BALB C , Infecções por Mycoplasma/veterinária , Doenças dos Roedores/imunologia , Animais , Anticorpos Antibacterianos/biossíntese , Testes de Hemaglutinação , Hipersensibilidade Tardia , Tolerância Imunológica , Imunidade Celular , Cinética , Ativação Linfocitária , Masculino , Camundongos , Mycoplasma/imunologia , Infecções por Mycoplasma/imunologia , Organismos Livres de Patógenos EspecíficosRESUMO
The distribution of a monoclonal antibody (MAb)-recognized protective protein immunogen on the outer membrane of 153 Pasteurella multocida rabbit isolates was determined by dot blot (DB) analysis. MAb 1608 reacted with 36 (24%) of the 153 clinical isolates. The DB-positive clinical isolates expressed capsular antigens A, D, and nontypable and somatic antigens 2, 3, 10, 12, 15, and nontypable. Western blot (immunoblot) analysis with adsorbed and eluted MAb 1608 confirmed that the antigenic determinant identified was located on the cell surface. With MAb 1608 as a probe for antibody-accessible radioimmunoassay, 31 of 36 DB-positive P. multocida rabbit isolates were shown to have surface-exposed and antibody-accessible antigenic determinants, while 44 of 44 DB-negative isolates were negative by antibody-accessible radioimmunoassay. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed DB-negative P. multocida isolates both with (6 of 13, 46%) and without (7 of 13, 54%) the 37.5-kilodalton protein. This study establishes that the protective antigenic determinant of the 37.5-kilodalton outer membrane protein is present in 24% of rabbit clinical isolates tested and is detectable in P. multocida strains distributed among the major somatic types (3, 10, 12, and 15) and the capsular types (A and D) commonly isolated from rabbits in North America.
Assuntos
Anticorpos Monoclonais/imunologia , Antígenos de Bactérias/análise , Infecções por Pasteurella/veterinária , Pasteurella/imunologia , Coelhos , Animais , Antígenos de Superfície/análise , Membrana Celular/imunologia , Eletroforese em Gel de Poliacrilamida , Epitopos/análise , Imunoensaio , Pasteurella/ultraestrutura , Infecções por Pasteurella/prevenção & controle , RadioimunoensaioRESUMO
Four groups of protective rabbit immune sera were used to identify Pasteurella multocida outer membrane immunogens by a radioimmunoprecipitation procedure and Western blot (immunoblot) analysis. These are rabbit hyperimmune sera against KSCN extract of P. multocida (group 1) and rabbit immune sera against the KSCN extract of P. multocida (group 2), the outer membrane of P. multocida (group 3), and live P. multocida cells (group 4). Rabbits mounted an antibody response to 18 proteins found in the outer membrane of P. multocida, and the major antibody activities were directed to the 27,000-molecular-weight outer membrane protein (27K protein), as well as the 37.5K, 49.5K, 58.7K, and 64.4K outer membrane proteins. These outer membrane immunogens appear to be exposed on the cell surface and accessible to antibodies, since adsorption of these immune sera with intact P. multocida cells resulted in a significant reduction of antibody activities directed against these proteins, especially the 37.5K protein. Antibodies eluted from immune serum-P. multocida cell complexes were reactive to the 37.5K immunogen, confirming that this protein is exposed on cell surface and accessible to antibodies. Western blot analyses with group 1, 3, and 4 immune sera confirmed that the 27K, 37.5K, 49.5K, 58.7K, and 64.4K proteins are the major outer membrane immunogens of P. multocida in rabbits. Lung lavages of immunized rabbits also contained similar antibody activities directed against several outer membrane proteins, with major activities against the 37.5K and 64.4K proteins.
Assuntos
Antígenos de Bactérias/isolamento & purificação , Proteínas da Membrana Bacteriana Externa/isolamento & purificação , Pasteurella/imunologia , Animais , Anticorpos Antibacterianos/biossíntese , Reações Antígeno-Anticorpo , Proteínas da Membrana Bacteriana Externa/imunologia , Líquido da Lavagem Broncoalveolar/análise , Soros Imunes , Imunoensaio , Peso Molecular , Pasteurella/análise , Testes de Precipitina , Coelhos , TiocianatosRESUMO
Humoral antibody response to sheep red blood cells and cellular immune response to bovine serum albumin were studied in Mycoplasma pulmonis infected, adult, male Sprague-Dawley rats. The hemagglutinating antibody response to sheep red blood cells was evaluated at 0, 3, 5, 7, 14, 21 and 28 days postinfection. Antibody titers during all days postinfection were depressed significantly (p less than 0.05) in infected rats as compared to noninfected controls. Cellular immune responses were evaluated by a delayed hypersensitivity response. Rats were sensitized at 0, 3, 5, 7, 14, 21 or 28 days postinfection with bovine serum albumin and challenged with heat aggregated bovine serum albumin 7 days later. Cell-mediated immune responses in infected rats were not significantly different at any point from controls. These results indicate that M. pulmonis infection in rats suppresses the humoral antibody response to sheep red blood cells, but not the cellular immune response to bovine serum albumin.